Therapy for Pediatric Hodgkin Lymphoma

NCT00145600 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

296

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

DRUG: 12 Week Stanford V Chemotherapy
DRUG: 4 cycles of VAMP chemotherapy
DRUG: 2 alternating cycles of VAMP/COP chemotherapy
DRUG: 3 alternating cycles of VAMP/COP chemotherapy

Sponsor

St. Jude Children's Research Hospital